Artal International Management S.A. 13D and 13G filings for Rubius Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 06:36 am Sale |
2021-12-31 | 13G | Rubius Therapeutics, Inc. RUBY |
Artal International Management S.A. | 3,701,580 4.100% |
-782,211 (-17.45%) |
Filing |
| 2021-03-08 4:30 pm Purchase |
2021-02-26 | 13G | Rubius Therapeutics, Inc. RUBY |
Artal International Management S.A. | 4,483,791 5.500% |
4,483,791 (New Position) |
Filing |